Buprenorphine hydrochloride
Buprenorphine hydrochloride is a semi-synthetic opioid used in the treatment of opioid addiction, acute pain, and chronic pain. It is a derivative of thebaine, an alkaloid found in the opium poppy. Buprenorphine hydrochloride is known for its high affinity for the mu-opioid receptor and its partial agonist activity, which makes it effective in reducing withdrawal symptoms and cravings in individuals with opioid dependence.
Pharmacology[edit | edit source]
Buprenorphine hydrochloride acts primarily as a partial agonist at the mu-opioid receptor and as an antagonist at the kappa-opioid receptor. Its partial agonist activity at the mu-opioid receptor provides analgesic effects and reduces the potential for abuse and respiratory depression compared to full agonists like morphine and heroin. The drug also has a high binding affinity, which means it can displace other opioids from the receptor, making it useful in the treatment of opioid overdose.
Medical Uses[edit | edit source]
Buprenorphine hydrochloride is used in various formulations for different medical purposes:
- Opioid Dependence: It is commonly used in medication-assisted treatment (MAT) for opioid dependence. It helps to reduce withdrawal symptoms and cravings, facilitating recovery and reducing the risk of relapse.
- Pain Management: Buprenorphine hydrochloride is used for managing moderate to severe pain. It is available in various forms, including transdermal patches and sublingual tablets.
Side Effects[edit | edit source]
Common side effects of buprenorphine hydrochloride include:
Serious side effects may include respiratory depression, especially when combined with other central nervous system depressants.
Administration[edit | edit source]
Buprenorphine hydrochloride can be administered in several forms, including:
The choice of administration depends on the condition being treated and the patient's needs.
Regulation and Legal Status[edit | edit source]
Buprenorphine hydrochloride is a controlled substance in many countries due to its potential for abuse and dependence. In the United States, it is classified as a Schedule III controlled substance under the Controlled Substances Act.
Related Pages[edit | edit source]
- Opioid
- Opioid dependence
- Medication-assisted treatment
- Mu-opioid receptor
- Kappa-opioid receptor
- Thebaine
- Opium poppy
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD